FMP

FMP

Enter

EPIX - ESSA Pharma Inc.

Terminal Value of ESSA Pharma Inc.(EPIX), ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprieta

photo-url-https://financialmodelingprep.com/image-stock/EPIX.png

ESSA Pharma Inc.

EPIX

NASDAQ

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

5.37 USD

0.74 (13.78%)

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep